Building a reproducible single-cell sequencing workflow to capture tumour persistence

The ultimate goal of the PERSIST-SEQ consortium is to improve the understanding of therapeutic resistance in cancer and create effective strategies to improve cancer treatment and prevent drug resistance.

icon_consortium
Consortium

14 European partners

 

icon_budget
Budget

14 million Euros

icon_period
Project duration

5 years

icon_startdate
Start date

1 July 2021

Share this page…